Respiratory medications
Dental Considerations for Patients Taking Anti-TB therapy (rifampicin / isoniazid)
Important — second opinion only. DentiCision provides an evidence-based second opinion to assist the dentist. It does not replace the treating dentist's professional clinical judgment or consultation with the patient's physician. The treating dentist retains full clinical, scientific and legal responsibility. Always verify drugs and doses against current guidelines.
Anti-TB therapy — rifampicin interactions
Rifampicin induces CYP3A4/CYP2C9; isoniazid, rifampicin and pyrazinamide are hepatotoxic.
Emergency vs routine management
If EMERGENCY — what to do
- • Do not delay emergency treatment — proceed with urgent care while applying the modifications listed above.Ref: CDC — Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings (MMWR 2005;54 RR-17), dental settings section
If ROUTINE — what to do
- • Proceed with routine care once the listed precautions, labs or timing checks are satisfied.Ref: CDC — Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings (MMWR 2005;54 RR-17), dental settings section
- • Book at the most suitable time and keep appointments short where advised.Ref: CDC — Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings (MMWR 2005;54 RR-17), dental settings section
Clinical precautions
- • Rifampicin is a strong enzyme inducer: reduces the effect of midazolam/oral benzodiazepines, warfarin (INR falls), DOACs and hormonal contraceptives
- • Isoniazid / rifampicin / pyrazinamide are hepatotoxic — paracetamol at reduced dose, avoid other hepatotoxic drugs
- • Also add Tuberculosis to record infectiousness
Medications to avoid → safer alternative
- Midazolam / oral benzodiazepine sedation (patient on rifampicin)Local anaesthesia with anxiety management; nitrous oxide
Rifampicin markedly reduces benzodiazepine levels — sedation unreliable.
At a glance by procedure
Initial assessment before lab results or timing details are entered.
| Procedure | Initial assessment |
|---|---|
| Examination / radiographs | MODIFY / CAUTION Anti-TB therapy — rifampicin interactions |
| Supragingival scaling / polish | MODIFY / CAUTION Anti-TB therapy — rifampicin interactions |
| Deep scaling / subgingival RSD (subgingival calculus) | MODIFY / CAUTION Anti-TB therapy — rifampicin interactions |
| Root canal treatment | MODIFY / CAUTION Anti-TB therapy — rifampicin interactions |
| Simple extraction (1–3 teeth) | MODIFY / CAUTION Anti-TB therapy — rifampicin interactions |
| Surgical / bony extraction | MODIFY / CAUTION Anti-TB therapy — rifampicin interactions |
| Implant placement | MODIFY / CAUTION Anti-TB therapy — rifampicin interactions |
References
- CDC — Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings (MMWR 2005;54 RR-17), dental settings section
- WHO consolidated guidelines on tuberculosis, Module 1: Prevention — infection prevention and control (2022)
- ADA Oral Health Topics — Tuberculosis: overview and dental treatment considerations
- BNF — Rifampicin interactions (CYP3A4 / CYP2C9 induction: midazolam, warfarin, DOACs)
Related guides
Important — second opinion only. DentiCision provides an evidence-based second opinion to assist the dentist. It does not replace the treating dentist's professional clinical judgment or consultation with the patient's physician. The treating dentist retains full clinical, scientific and legal responsibility. Always verify drugs and doses against current guidelines.